Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115629-115629
Closed Access | Times Cited: 40
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 34
CRISPR‐Mediated Profiling of Viral RNA at Single‐Nucleotide Resolution
Duo Chen, Wanting Huang, Yun Zhang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 30
Closed Access | Times Cited: 33
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 11
Transformative Approaches in SARS-CoV-2 Management: Vaccines, Therapeutics and Future Direction
Ankita Saha, Shweta Choudhary, Priyanshu Walia, et al.
Virology (2025) Vol. 604, pp. 110394-110394
Closed Access | Times Cited: 1
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 23
The gut microbe pair of Oribacterium sp. GMB0313 and Ruminococcus sp. GMB0270 confers complete protection against SARS-CoV-2 infection by activating CD8+ T cell-mediated immunity
Mingda Wang, Enkhchimeg Lkhagva, Sura Kim, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants
Xiang Liu, Wern Hann Ng, Eva Žusinaite, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection
Fan Zhou, Juha Vahokoski, Siri Øyen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 4
Structure-guided in vitro evolution of nanobodies targeting new viral variants
Gang Ye, Fan Bu, Ruangang Pan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012600-e1012600
Open Access | Times Cited: 4
Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
Ramadhita Umitaibatin, Azza Hanif Harisna, Muhammad Miftah Jauhar, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 399-399
Open Access | Times Cited: 11
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Masaud Shah, Sung Ung Moon, Ji‐Yon Shin, et al.
Advanced Science (2025)
Open Access
Immunological drivers of zoonotic virus emergence, evolution, and endemicity
Jyothi N. Purushotham, Holly L. Lutz, Edyth Parker, et al.
Immunity (2025)
Closed Access
Enhancing the understandings on SARS-CoV-2 main protease (Mpro) mutants from molecular dynamics and machine learning
Jiawen Wang, Juan Xie, Yi Yu, et al.
International Journal of Biological Macromolecules (2025), pp. 143076-143076
Closed Access
XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice
Jiawen Liu, Tiantian Wang, Hongying Ren, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 543-543
Open Access
Progress with COVID vaccine development and implementation
Richard W. Titball, David I. Bernstein, Nicolas V. J. Fanget, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Bacteriophage T4 as a Protein-Based, Adjuvant- and Needle-Free, Mucosal Pandemic Vaccine Design Platform
Jingen Zhu, Pan Tao, Ashok K. Chopra, et al.
Annual Review of Virology (2024) Vol. 11, Iss. 1, pp. 395-420
Closed Access | Times Cited: 3
Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike–ACE2 Interaction
Saja Almabhouh, Erika Cecon, Florence Basubas, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1750-1750
Open Access
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-Cov-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
(2023)
Open Access | Times Cited: 8
Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity
Valeria Gerardi, Mohammed A. Rohaim, Rania F. El Naggar, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 668-668
Open Access | Times Cited: 8
Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with “Spanish Flu”?
Florigio Lista, Mario Stefano Peragallo, Roberto Biselli, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 868-868
Open Access | Times Cited: 8
Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration
Mohammed Abdelaziz, Martin Raftery, Julian Weihs, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials
H. J. Yang, Weiqi Hong, Shi H, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top